Short title: Real-world Omalizumab and Mepolizumab outcomes
Authors: Wei Chern Gavin Fong*1,2 , Adnan Azim*2,3, Deborah Knight3, Heena Mistry1,2,3, Anna Freeman2,3, Mae Felongco2,3, Aref Kyyaly1,2,3, Matthew Harvey2,3, Patrick Dennison3, Hongmei Zhang4, Peter Howarth2,3 S Hasan Arshad1,2,3 and Ramesh J Kurukulaaratchy1,2,3
Affiliations: 1David Hide Asthma and Allergy Research Centre, Isle of Wight, UK. 2Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. 3 NIHR Southampton Biomedical Research Centre, University Hospitals Southampton NHS Foundation Trust, Southampton. 4Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA.
*contributed equally